169 related articles for article (PubMed ID: 33035473)
61. Detection of high-grade cervical disease among women referred directly to colposcopy after a positive HPV screening test varies with age and cytology findings.
Farnsworth A; Roberts JM; Garland SM; Crescini J; Kaldor JM; Machalek DA
Int J Cancer; 2020 Dec; 147(11):3068-3074. PubMed ID: 32484236
[TBL] [Abstract][Full Text] [Related]
62. Increases in Human Papillomavirus Testing Preceding Diagnosis of Cervical Precancer in 5 US States, 2008-2016.
Cleveland AA; Gargano JW; Griffin MR; Park IU; Niccolai LM; Bennett NM; Pemmaraju M; Fink D; Brackney M; Scahill M; Ehlers SJ; Unger ER; Markowitz LE;
J Low Genit Tract Dis; 2021 Jul; 25(3):192-198. PubMed ID: 33797511
[TBL] [Abstract][Full Text] [Related]
63. [Results and cost evaluation of triage with high risk HPV test in cervical cancer screening. A pilot study in Piedmont (North-West Italy)].
Magnani C; Gillio Tos A; De Marco L; Calvia M; Cipelletti A; Bestagini P; Pagano E; Segnan N; Ronco G
Epidemiol Prev; 2012; 36(2):88-94. PubMed ID: 22706358
[TBL] [Abstract][Full Text] [Related]
64. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
[TBL] [Abstract][Full Text] [Related]
65. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.
Ronco G; Dillner J; Elfström KM; Tunesi S; Snijders PJ; Arbyn M; Kitchener H; Segnan N; Gilham C; Giorgi-Rossi P; Berkhof J; Peto J; Meijer CJ;
Lancet; 2014 Feb; 383(9916):524-32. PubMed ID: 24192252
[TBL] [Abstract][Full Text] [Related]
66. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
Demarco M; Lorey TS; Fetterman B; Cheung LC; Guido RS; Wentzensen N; Kinney WK; Poitras NE; Befano B; Castle PE; Schiffman M
J Low Genit Tract Dis; 2017 Oct; 21(4):261-267. PubMed ID: 28953116
[TBL] [Abstract][Full Text] [Related]
67. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
[TBL] [Abstract][Full Text] [Related]
68. Five-year risks of CIN 3+ and cervical cancer among women with HPV-positive and HPV-negative high-grade Pap results.
Katki HA; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Gage JC; Kinney WK
J Low Genit Tract Dis; 2013 Apr; 17(5 Suppl 1):S50-5. PubMed ID: 23519305
[TBL] [Abstract][Full Text] [Related]
69. Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
Song F; Yan P; Huang X; Wang C; Du H; Qu X; Wu R
BMC Cancer; 2022 Jan; 22(1):42. PubMed ID: 34991494
[TBL] [Abstract][Full Text] [Related]
70. The clinical performance of primary HPV screening, primary HPV screening plus cytology cotesting, and cytology alone at a tertiary care hospital.
Choi JW; Kim Y; Lee JH; Kim YS
Cancer Cytopathol; 2016 Feb; 124(2):144-52. PubMed ID: 26457676
[TBL] [Abstract][Full Text] [Related]
71. Incidence of abnormal cervical and vaginal cytology among women over age 65 years living with human immunodeficiency virus.
Stewart KA; Allen SM; Chesnokova AE; Syed F; Levison JE
Am J Obstet Gynecol; 2020 May; 222(5):486.e1-486.e10. PubMed ID: 31678094
[TBL] [Abstract][Full Text] [Related]
72. Factors associated with high-risk human papillomavirus test utilization and infection: a population-based study of uninsured and underinsured women.
Llanos AAM; Tsui J; Rotter D; Toler L; Stroup AM
BMC Womens Health; 2018 Oct; 18(1):162. PubMed ID: 30285820
[TBL] [Abstract][Full Text] [Related]
73. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
[TBL] [Abstract][Full Text] [Related]
74. Management of women with human papillomavirus persistence: long-term follow-up of a randomized clinical trial.
Elfgren K; Elfström KM; Naucler P; Arnheim-Dahlström L; Dillner J
Am J Obstet Gynecol; 2017 Mar; 216(3):264.e1-264.e7. PubMed ID: 27825977
[TBL] [Abstract][Full Text] [Related]
75. [Performance of combined liquid based cytology and HPV nucleic acid test for detecting cervical precancer among women attending screening].
Jiang MY; Feng RM; Wang L; Li TY; Zhang AA; Cui JF; Pan QJ; Zhang X; Liu ML; Gao F; Chen W; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):750-756. PubMed ID: 30392339
[No Abstract] [Full Text] [Related]
76. Long term results of follow-up after HPV self-sampling with devices Qvintip and HerSwab in women non-attending cervical screening programme.
Bokan T; Ivanus U; Jerman T; Takac I; Arko D
Radiol Oncol; 2021 Jan; 55(2):187-195. PubMed ID: 33764704
[TBL] [Abstract][Full Text] [Related]
77. Cervical cancer screening of underserved women in the United States: results from the National Breast and Cervical Cancer Early Detection Program, 1997-2012.
Tangka FK; Howard DH; Royalty J; Dalzell LP; Miller J; O'Hara BJ; Sabatino SA; Joseph K; Kenney K; Guy GP; Hall IJ
Cancer Causes Control; 2015 May; 26(5):671-86. PubMed ID: 25783455
[TBL] [Abstract][Full Text] [Related]
78. Five-year risks of CIN 3+ and cervical cancer among women who test Pap-negative but are HPV-positive.
Katki HA; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Gage JC; Kinney WK
J Low Genit Tract Dis; 2013 Apr; 17(5 Suppl 1):S56-63. PubMed ID: 23519306
[TBL] [Abstract][Full Text] [Related]
79. Effect of Sequential Rounds of Cervical Cancer Screening on Management of HPV-positive Women: A 15-year Population-based Cohort Study from China.
Xu XQ; Rezhake R; Hu SY; Chen F; Zhang X; Pan QJ; Zhang WH; Ma JF; Qiao YL; Zhao FH; Cruickshank M
Cancer Prev Res (Phila); 2021 Mar; 14(3):363-372. PubMed ID: 33303694
[TBL] [Abstract][Full Text] [Related]
80. A study of the risks of CIN3+ detection after multiple rounds of HPV testing: Results of the 15-year cervical cancer screening experience at Kaiser Permanente Northern California.
Hammer A; Demarco M; Campos N; Befano B; Gravitt PE; Cheung L; Lorey TS; Poitras N; Kinney W; Wentzensen N; Castle PE; Schiffman M
Int J Cancer; 2020 Sep; 147(6):1612-1620. PubMed ID: 32141607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]